Anders Wittrup
WCMM Clinical Researcher | Tumor Microenvironment Our research Despite recent advances, there is still a substantial unmet medical need for novel cancer therapeutics. A new class of pharmacological compounds, based on RNA, open up new possibilities to specifically target numerous cancer cell vulnerabilities. Cytosolic delivery of the macromolecular RNA molecules is the biggest hurdle to translate
https://www.wcmm.lu.se/anders-wittrup - 2025-06-19